- ►annals.org M Shindo, K Arai, Y Sokawa, T Okuno - Annals of internal medicine, 1995 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook
Add to Reddit Add to Technorati Add to Twitter What's this? ... Objective: To identify predictors
of a long-term response to interferon- therapy in chronic hepatitis C and to determine ... Cited by 78 - Related articles - All 3 versions
M Shindo, K Arai, T Okuno - Journal of hepatology, 1997 - Elsevier Results: The patients were divided into two groups according to the outcome of serum alanine
aminotransferase levels and HCV RNA level during and after therapy: 31 long-term responders
whose serum aminotransferase level became and remained normal for 1 year after ... Cited by 18 - Related articles - BL Direct - All 6 versions
O Reichard, H Glaumann, A Frydén, G Norkrans, R … - Hepatology, 1995 - interscience.wiley.com Fourteen patients with chronic hepatitis C who had a sustained response to a 60-week interferon
alfa-2b treatment course were followed, biochemically and virologically, 2 years after treatment
cessation. Biopsies were repeated in 12 of 14 for histological and virological evaluation at ... Cited by 88 - Related articles - BL Direct - All 3 versions
R Romeo, S Pol, P Berthelot, C Brechot - Annals of internal medicine, 1994 - Am Coll Physicians Hepatitis C virus (HCV) is the main cause of chronic non-A, non-B hepatitis developing after
transfusion [1]; many patients (50% to 60%) become chronic carriers, of whom as many as
20% develop cirrhosis. In approximately 25% of patients, referred to as long-term ... Cited by 36 - Related articles - All 3 versions
GL Davis - Journal of hepatology, 1994 - cat.inist.fr PREDICTION OF RESPONSE TO INTERFERON TREATMENT OF CHRONIC HEPATITIS
C. GL DAVIS Journal of hepatology 21:11, 1-3, Elsevier, 1994.
Cited by 118 - Related articles - BL Direct - All 3 versions
S Kiso, S Kawata, S Tamura, Y Imai, Y Inui, T … - Journal of …, 1997 - Springer Abstract: The efficacy of interferon-a therapy in the treatment of chronic hepatitis C is still
limited. A com- bination therapy of interferon-a with ursodeoxycholic acid (UDCA) was tested
for its efficacy in the treatment of chronic hepatitis C by a randomized controlled study. ... Cited by 12 - Related articles - BL Direct - All 3 versions
J Camps, M Garcia-Granero, JI Riezu-Boj, E … - Journal of …, 1994 - ncbi.nlm.nih.gov 1: J Hepatol. 1994 Jul;21(1):4-11. Comment in: J Hepatol. 1994 Jul;21(1):1-3. Prediction of
sustained remission of chronic hepatitis C after a 12-month course of alfa interferon. Camps J,
García-Granero M, Riezu-Boj JI, Larrea E, de Alava E, Civeira MP, Castilla A, Prieto J. ... Cited by 42 - Related articles - BL Direct - All 2 versions
LA Balart, R Perrillo, J Roddenberry, F Regenstein … - … (New York, NY. 1943), 1993 - cat.inist.fr Hepatitis C RNA in liver of chronic hepatitis C patients before and after interferon alfa treatment.
LA BALART, R PERRILLO, J RODDENBERRY, F REGENSTEIN, KYU-SIK SHIM, YSC SHIEH,
B TAYLOR, S DASH, MA GERBER Gastroenterology(New York, NY. ... Cited by 57 - Related articles - BL Direct - All 4 versions
A Larghi, A Tagger, A Crosignani, ML … - Journal of medical …, 1998 - interscience.wiley.com Whether sustained biochemical response and absence of serum HCV RNA in the 6-12 months
following suspension of interferon- (IFN- ) therapy reflect definitive viral clearance in patients
with chronic hepatitis C virus (HCV) infection is controversial. To obtain more information ... Cited by 29 - Related articles - BL Direct - All 3 versions
M Mizokami, E Orito, Y Gibo, K Suzuki, K Ohba, T Ohno … - Liver, 1996 - interscience.wiley.com Abstract: To determine whether pretreatment HCV-RNA level, hepatitis C virus genotypes, alanine
aminotransferase and histology correlate with subsequent response to interferon-α therapy or
not, serum HCV-RNA levels and genotype were determined by branched DNA signal ... Cited by 35 - Related articles - BL Direct - All 3 versions
